作者:Emil Lindbäck、Óscar Lopéz、Ådne Tobiesen、José G. Fernández-Bolaños、Magne O. Sydnes
DOI:10.1039/c7ob01673e
日期:——
hydrazide imide moiety is described. The sugar hydrazide imides (3S,4S,5R,6R)-1-amino-3,4,5-trihydroxy-6-(hydroxymethyl)-2-iminopiperidine acetate and (3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-imino-1-(methylamino)piperidine acetate presented here behave as inhibitors of α/β-glucosidases in the low micromolar concentration range. The former inhibitor displays a pH-dependent inhibition of β-glucosidase
描述了包括酰肼酰亚胺部分的新型亚氨基糖的制备。糖酰肼酰亚胺(3 S,4 S,5 R,6 R)-1-氨基-3,4,5-三羟基-6-(羟甲基)-2-亚氨基哌啶乙酸酯和(3 S,4 S,5 R在此呈现的,6 R)-3,4,5-三羟基-6-(羟甲基)-2-亚氨基-1-(甲基氨基)哌啶乙酸盐在低微摩尔浓度范围内充当α/β-葡糖苷酶的抑制剂。前一种抑制剂表现出pH依赖性的β-葡萄糖苷酶抑制作用。所述Ñ甲基化的对应物表现为α葡萄糖苷酶的端基异构体选择性的竞争性微摩尔抑制剂。